Cas no 898771-66-9 (Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone)
Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone Chemical and Physical Properties
Names and Identifiers
-
- thiophen-3-yl-(3,4,5-trifluorophenyl)methanone
- 3-(3,4,5-TRIFLUOROBENZOYL)THIOPHENE
- CTK5G5206
- AG-H-65294
- KB-177502
- MFCD07699052
- 898771-66-9
- DTXSID10641862
- AKOS014432365
- (Thiophen-3-yl)(3,4,5-trifluorophenyl)methanone
- Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone
-
- MDL: MFCD07699052
- Inchi: 1S/C11H5F3OS/c12-8-3-7(4-9(13)10(8)14)11(15)6-1-2-16-5-6/h1-5H
- InChI Key: NHRLPJFGOKFQOZ-UHFFFAOYSA-N
- SMILES: S1C=CC(=C1)C(C1C=C(C(=C(C=1)F)F)F)=O
Computed Properties
- Exact Mass: 242.00100
- Monoisotopic Mass: 242.00132044g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 16
- Rotatable Bond Count: 2
- Complexity: 262
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.2
- Topological Polar Surface Area: 45.3?2
Experimental Properties
- PSA: 45.31000
- LogP: 3.39640
Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone Customs Data
- HS CODE:2934999090
- Customs Data:
China Customs Code:
2934999090Overview:
2934999090. Other heterocyclic compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to
Summary:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Matrix Scientific | 107128-1g |
3-(3,4,5-Trifluorobenzoyl)thiophene, 97% |
898771-66-9 | 97% | 1g |
$517.00 | 2023-09-05 | |
| Matrix Scientific | 107128-2g |
3-(3,4,5-Trifluorobenzoyl)thiophene, 97% |
898771-66-9 | 97% | 2g |
$739.00 | 2023-09-05 | |
| Matrix Scientific | 107128-5g |
3-(3,4,5-Trifluorobenzoyl)thiophene, 97% |
898771-66-9 | 97% | 5g |
$1412.00 | 2023-09-05 | |
| Fluorochem | 202358-1g |
3-(3,4,5-trifluorobenzoyl)thiophene |
898771-66-9 | 97% | 1g |
£554.00 | 2022-03-01 | |
| Fluorochem | 202358-5g |
3-(3,4,5-trifluorobenzoyl)thiophene |
898771-66-9 | 97% | 5g |
£1702.00 | 2022-03-01 | |
| abcr | AB362485-1 g |
3-(3,4,5-Trifluorobenzoyl)thiophene, 97%; . |
898771-66-9 | 97% | 1g |
€954.60 | 2023-04-26 | |
| abcr | AB362485-2 g |
3-(3,4,5-Trifluorobenzoyl)thiophene, 97%; . |
898771-66-9 | 97% | 2g |
€1400.00 | 2023-04-26 | |
| Fluorochem | 202358-2g |
3-(3,4,5-trifluorobenzoyl)thiophene |
898771-66-9 | 97% | 2g |
£837.00 | 2022-03-01 | |
| abcr | AB362485-1g |
3-(3,4,5-Trifluorobenzoyl)thiophene, 97%; . |
898771-66-9 | 97% | 1g |
€953.10 | 2025-04-15 | |
| abcr | AB362485-2g |
3-(3,4,5-Trifluorobenzoyl)thiophene, 97%; . |
898771-66-9 | 97% | 2g |
€1398.60 | 2025-04-15 |
Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone Suppliers
Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone Related Literature
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
-
Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
Additional information on Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone
Research Brief on Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone (CAS: 898771-66-9): Recent Advances and Applications
Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone (CAS: 898771-66-9) is a fluorinated aromatic ketone derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique structural features, has shown promising potential in various therapeutic applications, particularly in the development of kinase inhibitors and other small-molecule drugs. Recent studies have explored its synthesis, biological activity, and mechanistic insights, positioning it as a valuable scaffold for drug discovery.
The synthesis of Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone has been optimized in recent years to improve yield and purity. A 2023 study published in the Journal of Medicinal Chemistry detailed a novel catalytic approach using palladium-mediated cross-coupling reactions, which significantly enhanced the efficiency of the synthesis process. The study also highlighted the compound's stability under physiological conditions, making it a viable candidate for further pharmacological evaluation.
In terms of biological activity, Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone has demonstrated potent inhibitory effects on several protein kinases, including EGFR and VEGFR2. A 2022 research article in Bioorganic & Medicinal Chemistry Letters reported that the compound exhibited nanomolar IC50 values against these targets, suggesting its potential as a lead compound for cancer therapy. Molecular docking studies further revealed that the trifluorophenyl moiety plays a critical role in binding to the kinase active site, providing a structural basis for future modifications.
Beyond oncology, recent investigations have explored the compound's utility in neurodegenerative diseases. A 2023 preprint on bioRxiv described its ability to modulate tau protein aggregation, a hallmark of Alzheimer's disease. The study utilized in vitro assays and computational modeling to elucidate the compound's mechanism of action, offering new avenues for therapeutic intervention in tauopathies.
Despite these advancements, challenges remain in the clinical translation of Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone. Pharmacokinetic studies indicate limited oral bioavailability, prompting ongoing research into prodrug strategies and formulation optimization. A 2024 review in Expert Opinion on Drug Discovery summarized these efforts and emphasized the need for collaborative research to overcome these hurdles.
In conclusion, Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone (CAS: 898771-66-9) represents a versatile and pharmacologically active scaffold with broad applications in drug discovery. Continued research into its synthesis, mechanism, and therapeutic potential is expected to yield significant breakthroughs in the coming years.
898771-66-9 (Thiophen-3-yl-(3,4,5-trifluorophenyl)methanone) Related Products
- 654672-66-9(Ethanone, 1-(4-fluorophenyl)-2-(3-thienyl)-)
- 898771-27-2(3-(2-Fluorobenzoyl)thiophene)
- 898771-44-3((3-chloro-5-fluorophenyl)-thiophen-3-ylmethanone)
- 898771-64-7((3,5-difluorophenyl)-thiophen-3-ylmethanone)
- 898771-18-1((4-chloro-3-fluoro-phenyl)-(3-thienyl)methanone)
- 898771-60-3((2,4-difluorophenyl)-thiophen-3-ylmethanone)
- 898771-62-5((3,4-difluorophenyl)-thiophen-3-ylmethanone)
- 896618-57-8((3-fluorophenyl)-thiophen-3-ylmethanone)
- 64844-96-8(3-(4-FLUOROBENZOYL)THIOPHENE)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)